Vertex Pharmaceuticals Incorporated (ETR:VX1)
Germany
· Delayed Price · Currency is EUR 434.65
+2.50 (0.58%)
Apr 25, 2025, 10:32 AM CET
Vertex Pharmaceuticals Market Cap
Vertex Pharmaceuticals has a market cap or net worth of €111.50 billion as of April 25, 2025. Its market cap has increased by 15.85% in one year.
Market Cap
111.50B
Enterprise Value
103.16B
Revenue
10.64B
Ranking
n/a
PE Ratio
n/a
Stock Price
€434.65
Market Cap Chart
Since July 24, 1991, Vertex Pharmaceuticals's market cap has increased from 73.88M to 111.50B, an increase of 150,814.45%. That is a compound annual growth rate of 24.20%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 51.22B |
| Siemens Healthineers AG | 50.02B |
| Fresenius SE & Co. KGaA | 22.28B |
| Bayer Aktiengesellschaft | 21.11B |
| Sartorius Aktiengesellschaft | 13.88B |
| Fresenius Medical Care AG | 12.35B |
| Carl Zeiss Meditec AG | 5.19B |
| Fielmann Group AG | 3.66B |